including multiple-membered gene families is hypothesized to contribute to host 48 manipulation. We have tested this hypothesis by in vivo expression of two members of a 49 family of Polydnavirus homologues of Innexins, or insect gap junction proteins. Previous 50 findings demonstrated that the two Vinnexins induce different physiological alterations in 51 heterologous systems. Here, in host caterpillars, we observed differential alteration by 52 the two proteins of host immune cell (hemocyte) bioelectrical physiology and the immune 53 response of encapsulation. Not only do our data suggest a linkage between cellular 54 bioelectricity and immunity in insects, but they support that gene family expansion has 55 functional consequences to both Polydnavirus and host wasp success. 56 57 58
Introduction 59
Polydnaviruses (PDVs) are a remarkable virus family. These large dsDNA viruses are 60 obligately and mutualistically associated with specific families of parasitoid wasps, a 61 relationship that generates unusual selection pressures on the viruses. The association 62 of these viruses with their wasp hosts is essential to the ecological and evolutionary 63 success of those wasps. PDVs are actually a paraphyletic linage: Bracoviruses (BVs), 64 associated with PDVs are associated with microgastroid complex of the wasp family 65
Braconidae, while Ichnoviruses (IVs) are associated with Campopleginae and Banchinae 66 wasp subfamilies of the wasp family Ichneumonidae. Despite their evolutionary 67 independence, the different lineages of PDVs exhibit similar genome organization and 68 are integrated as a provirus into the genome of the host wasp. The genome of members 69 of both lineages is comprised by large dsDNA across multiple segments, of which a 70 majority of the sequence is non-coding, while coding sequences cluster into numerous 71 multimember gene families (1, 2). The PDV genome is transmitted vertically as a 72 provirus in the wasp genome, while horizontal transmission occurs across species 73 boundary: PDV replication and encapsidation precedes oviposition, during which virus is 74 introduced along with egg into the hemocoel of a parasitized insect (typically caterpillar) 75 host. Infection followed by expression of virus genes results in numerous host 76 pathophysiologies, including disruptions of the immune, energy homeostatic and 77 endocrine systems, which provide a beneficial environment to the developing wasp (2-78 4). There is no evidence of PDV replication in the infected secondary host during this 79 period (5). 80
81
As virus replication does not occur in the caterpillar host, it generally has been held that 82 PDV genes expressed in that host play a role in generating pathophysiology (3, 6, 7). 83 Therefore, expansion of PDV genes into gene families has been viewed as evidence of 84 selection for manipulation of additional hosts and/or tissues and processes within a host 85 (8, 9). Assigning function to PDV genes then provides insight into the mechanisms by 86 which PDVs manipulate the insect host of the PDV, i.e., the mechanisms by which the 87 associated parasitoid manipulates the host. However, due to the complexities of the 88 association between wasp and virus, it can be difficult to assess the roles of individual 89 genes and/or gene families. Thus, work in both BVs and IVs has sought to elucidate 90 PDV gene function, typically testing sufficiency using in vitro assays or necessity via 91
RNAi during PDV infection (10-14). 92 93 5 Total IV gene expression is associated with multiple host pathologies, such as 94 alterations of cytoskeleton (15-17) and disruption of cell signaling (10). IV protein 95 functional analyses have mostly focused on the cys-motif family found in all IV genomes 96 to date (18-20), especially its role in suppressing immune system and manipulating host 97 translation (21-23). The vinnexins are another IV multimember gene family (24). These 98 genes are virus homologues of insect gap junction genes (innexins) and are highly 99 
Results 120
In vivo recombinant protein expression. We utilized recombinant baculoviruses that or vnxQ2, or the same volume of virus-free media. Hemocyte protein was isolated and 129 analyzed by anti-His western blot, which verified recombinant protein expression in 130 hemocyte samples ( Fig. 1A) . We also examined protein expression in hemocytes using 131 epifluorescence immunomicroscopy. Anti-His ( Fig. 1B) and anti-FLAG 132 immunomicroscopy results (Fig. 1C) corresponded to patterns observed with expression 133 of VnxG-His, VnxQ2-His, and FLAG-Mc4r in infected Sf9 cells (27). We simultaneously 134 probed with an antibody against the AcMNPV envelope protein GP64 to determine rate 135 of AcMNPV infection, and typically observed rates in excess of 90%. 136
Infection with vinnexin recombinant baculoviruses increases caterpillar mortality. 137
H. virescens is a permissive host to wild type AcMNPV, the baculovirus we used for 138 recombinant virus generation. We tested whether recombinant vinnexin expression 139 altered mortality in the presence of an AcMNPV infection. Media or media plus 100 pfu 140 budded control or experimental recombinant AcMNPV was injected intrahemocoelically, 141 and larval mortality was assessed daily for 7d. Approximately 10% of mock infected 142 (media) larvae died during the period, while the control Mc4r virus treatment resulted in 7 ~40% mortality and both Vinnexin recombinants resulted in >85% mortality (Fig. 2) . 144
Bonferroni correction was conducted ahead of multiple comparison (α'=0.0083). 145
AcMNPV-Mc4r induced significantly higher mortality relative to Mock control (p<0.008). 146
Infection with either vinnexin recombinant virus resulted in significantly greater mortality 147 than the Mc4r recombinant virus (p<0.008), although there was no difference between 148 the VnxG and VnxQ2 infection results (p=0.43). 149
Infection with vinnexin recombinant baculoviruses slows development of host 150
caterpillar. Next, the consequence of Vinnexin expression on developmental rate was 151 examined. A significant difference in proportion of larvae molting from 4th to 5th instar 152 was observed ( Fig. 3, χ2 (3, N=4) = 58.21, p<0.01). Larvae injected with 100 pfu of 153 control AcMNPV-Mc4r did not significantly differ from larvae injected with media in the 154 percentage molting from 4th to 5th instar by 3 dpi (p=0.24). However, both vinnexin 155 recombinants differed significantly from both media and AcMNPV-mc4r treatments, with 156 significantly more of the vnxG-infected and vnxQ2-infected larvae failing to molt to 5th 157 instar. Furthermore, there was a significant difference between vnxG-infected and 158 vnxQ2-infected (p=0.02), with significantly fewer AcMNPV-vnxG-injected larvae molting. 159
Vinnexin expression has no effect on Total Hemocyte Counts (THC). Previously, we 160 demonstrated that Sf9 cells infected with AcMNPV-vnxG and AcMNPV-vnxQ2 exhibited 161 a significant reduction in cell number relative to Mock-infected and AcMNPV-mc4r-162 infected cells (27). As a high percentage of hemocytes of larvae injected with the three 163 viruses were GP64 positive, indicating hemocytes were infected with the viruses, we 164 tested whether infection likewise altered hemocyte number in vivo. Although there was a 165 trend to reduced THC in virus infected larvae relative to mock infected, the reduction 166 was not significant (ANOVA, F (3,8) =0.21, p =0.89) ( Fig. 4) . There was no significant 167 8 difference between the THC of Vinnexin-infected and Mc4r-infected larvae (p >0.90) or 168 the VnxG-infected and VnxQ2-infected larvae (p >0.99). 169
Vinnexin expression depolarizes cell membranes. Membranes of Sf9 cells infected 170
with AcMNPV-vnxG or AcMNPV-vnxQ2 were found to be significantly depolarized 171 relative to controls in a previous study (27) . To test for this phenomenon in vivo, we 172 isolated hemocytes from mock-and recombinant AcMNPV-infected larvae and 173 incubated them with the membrane potential sensitive dye DiBAC4(3). Cells were 174 manually outlined, and area and normalized intensity determined. Cell area differed 175 significantly between treatments (ANOVA, F(3,1116) =36.53, p < 0.01) ( Fig. 5A) . While 176
AcMNPV-mc4r infection did not alter area relative to mock (p = 0.99), hemocytes from 177
both AcMNPV-vnxG (p < 0.01) and AcMNPV-vnxQ2 (p < 0.01) infected larvae were 178 significantly smaller than those of AcMNPV-Mc4r control. Hemocytes isolated from 179 vnxG-infected larvae were significantly smaller than those from the vnxQ2-infected 180 larvae (p < 0.01). 181
Normalized DiBAC4(3) intensity (i.e., Vmem) was significantly affected by recombinant 182 virus infections relative to mock (ANOVA, F(3,1116) = 121.6, p < 0.01) ( Fig. 5B) . forming a regular shaped capsule (2 on the scale used), while <20% of beads showed 197 irregular or no encapsulation (1 on scale) ( Fig. 6A-B) . Hemocytes from AcMNPV-vnxQ2-198
injected individuals failed to encapsulate nearly 50% of the presented beads. AcMNPV-VnxQ2 had more partial encapsulation, the proportion was not significantly 211 different from either Mock (χ2 = 3.857, p = 0.05) or AcMNPV-Mc4r (χ2 = 3.857, p = 0.05). 212 213
Discussion 214
The relationship of PDVs to their host wasp has long suggested to researchers that 215 expansion of the virus gene families should result in altered host susceptibility (33, 34). 216
Such susceptibility may take the form of additional susceptible hosts, increased numbers 217 of pathways affected, or multiple tissues affected. This potential differential pathology 218 has not been systematically analyzed functionally, in part due to the recalcitrance of 219
PDVs to experimental manipulation and analysis: PDVs have multiple genes per gene 220 family (35), with dynamic expression profiles that may differ across hosts (18, 19), and 221 there currently is no in vitro system to streamline genetic manipulation for high-222
throughput study. Given the breadth of the potential impacts of genes and the difficulty of 223 genetic screening, it is not surprising that few PDVs have been systematically analyzed. 28)], it seems more likely that the molt pathology associated with them is general rather 250 than targeted for the developmental system, as transcription of all four vinnexins is 251 detected in all tested tissues in infected H. virescens (24). To that end, we suspect that 252 the developmental delay observed here is due to cryptic cell death and loss of 253 homeostasis, rather than pathology specific to the molting axis. 254
We also recapitulated previous in vitro observations of Vinnexin-specific alteration of 255 membrane potential. Previously, we demonstrated that CsIV VnxG and VnxQ2 induce 256 membrane depolarization and cytoplasmic alkalization in expressing Sf9 cells (27). Here, 257
we found that hemocytes isolated from individuals infected with the vnxG-recombinant 258 virus were depolarized relative to those isolated from vnxQ2-recombinant infected 259 individuals, which in turn were depolarized relative to mock and control recombinant-260 infected hemocytes (Fig. 5) . Intriguingly, little examination of the relationship between 261 hemocyte function and membrane potential, as well as with endogenous and exogenous 262 electrical fields, has been performed in insects. Caterpillar hemocytes undergo 263 depolarization during immune stimulation (43), although the mechanism(s) and VnxG forms stronger, more reliable gap junctions in Xenopus oocytes (24, 26), its 284 expression is embryonic lethal in D. melanogaster embryos while VnxQ2 is not (28) and 285
VnxG is more strongly alkalizing and depolarizing in the Spodoptera frugiperda-derived 286
Sf9 cell line (27). Reduced pathogenicity is observed with VnxQ2 in these different 287 systems, suggesting that while VnxQ2 is competent for interacting with host cells in a 288 consistent fashion, it does so to a lesser effect than VnxG. While the question remains 289
as to the evolvability of the system, it does suggest that VnxQ2 is less pathogenic than 290
VnxG has evolved to be. 291
13
We performed descriptive and functional assays representing multiple physiological 292 systems within the host H. virescens for two members of the CsIV vinnexin gene family. 293
We observed significant variation in functionality between VnxG and VnxQ2, which is 294 consistent with direction when compared to other tested systems. Our results thus 295 suggest that the Vinnexins interact consistently and reliably between systems across 296 hosts. However, it remains to be tested whether Vinnexins equally affect different hosts, 297 which will be essential to address their potential role in evolution of host range and 298 physiological susceptibility. 299 300 301
Methods 302

Insect Rearing 303
Third instar H. virescens caterpillars were purchased (Benzon Research, Carlisle, PA) 304 and reared at 27°C. Newly molted 4th instar larvae, staged according to head capsule 305 width (45), were used for experiments, and were maintained at 27°C after treatment for 306 data collection. 307 308
Recombinant Virus Generation and Injection 309
The recombinant baculoviruses used for in vivo expression of vnxG-His and vnxQ2-His 310 or control virus, FLAG-mc4r, were generated with Bac-to-Bac vector system (Invitrogen). Precast Gels) and transferred to PVDF membrane. Blots were probed with rabbit anti-331
His antibody (Thermo Fisher Scientific) at 1: 1,000 in blocking solution at 4 °C overnight, 332 and then probed with polyclonal donkey anti-rabbit HRP-antibody (Invitrogen) at 1: 5,000 333 in blocking solution at room temperature for 1h. After washing, blots were treated with 334 ECL substrate (Thermo Fisher Scientific), developed and visualized on X-ray film. 335
For immunomicroscopy, 104 infected hemocytes was seeded in chamber slide, fixed with 336 4% formaldehyde (in PBS) at room temperature for 15 min, permeabilized with PBST 337 (PBS + 0.2% TritonX-100) at room temperature for 10 min and blocked with 5% FBS (in 338 PBST) at room temperature for 60 min with washing in PBS between every step. 339
Primary (rabbit anti-His, Thermo Fisher Scientific) and secondary (anti-rabbit Alexa Fluor 340 594, Jackson ImmunoResearch) antibodies were diluted in blocking solution and applied 341 at 1: 200 and 1: 1,000, incubated at 4 °C overnight and room temperature for 1 h, 342
respectively. Images were captured on a Nikon TE2000 epifluorescence microscope 343 with NIS Elements BR 2.3 software. 344 345
Caterpillar Survival and Development 346
Thirty newly molted 4th instar larvae were injected with media or recombinant virus as 347 above, and monitored daily for mortality for one week. Caterpillars were recorded as live, 348 dead or pupated. Dead caterpillars were removed from diet tray after counting to avoid 349 contamination. Larvae that died during the first three days were considered as mortality 350 due to physical damage, and were removed from analyses. The instar of each 351 caterpillar was recorded at 3 dpi and the proportion of 4th instar caterpillar was 352 calculated. Each treatment was replicated 3 times. 353
354
Hemocyte Count Determination and Vmem Measurement 355
Hemocytes were collected and washed as described above. Hemocyte counts were 356 determined with a Neubauer hemocytometer, with three replicates per treatment. To 357 measure the membrane potential of hemocytes, 104 hemocytes were seeded in a 96-358 well plate and given 15 min to attach. At that time, Bis-(1,3-Dibutylbarbituric Acid) 359
Trimethine Oxonol (DiBAC4(3)) was added to 1 µg/ml and allowed to incubate for 10 min 360 in the dark. Hemocytes were imaged and analyzed as previously described (27). In brief, 361 images were captured with a DS-Qi1Mc monochromatic camera on a Nikon TE2000 362 epifluorescence microscope with FITC filters. Cell intensity was collected by randomly 363
choosing individual cells and manually generating the outline of cells as a Region of 364
Interest (ROI). Normalized mean intensity (NMI) was calculated for each ROI by 365 normalizing the ROI mean intensity (RMI) to background (BACK) and ambient light 366 
Ex Vivo Encapsulation Assay 370
To test ability of hemocytes to engage in encapsulation, DEAE Sephadex beads were 371 used as targets in ex vivo encapsulation assay. One million hemocytes of from treatment 372 were placed in a 48-well plate coated with a layer 0.5% sterilized agarose (47). Ten 373 beads, hydrated and sterilized, were added to each well. After 3 h incubation, beads 374 were collected by gentle pipetting and transferred to a slide and only intact beads were 375 examined for encapsulation. Beads were scored as "Normal encapsulation" if they were 376 completely surrounded by multiple layers of hemocytes. "Abnormal encapsulation" 377 noted both partial encapsulation-75% surface was surrounded by hemocytes and as 378 intense encapsulation-the encapsulation was several times as big as bead itself. 379
Immune assay was repeated 5 times and at least 21 beads were examined for each 380 treatment. 
